Arno Floore

4.3k total citations · 1 hit paper
33 papers, 2.8k citations indexed

About

Arno Floore is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Arno Floore has authored 33 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Arno Floore's work include Breast Cancer Treatment Studies (8 papers), Cancer Diagnosis and Treatment (7 papers) and Cancer Genomics and Diagnostics (6 papers). Arno Floore is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Cancer Diagnosis and Treatment (7 papers) and Cancer Genomics and Diagnostics (6 papers). Arno Floore collaborates with scholars based in Netherlands, United States and Germany. Arno Floore's co-authors include Annuska M. Glas, Emiel J. Rutgers, Laura J. van’t Veer, Fátima Cardoso, Laura van’t Veer, Giuseppe Viale, Jan Bogaerts, Martine Piccart, Laura van ‘t Veer and Anke Witteveen and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Cell.

In The Last Decade

Arno Floore

32 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

2006 842 citations Marc Buyse, Sherene Loi et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arno Floore Netherlands	20	1.5k	1.3k	1.3k	592	471	33	2.8k
Magali Lacroix‐Triki France	29	1.4k 1.0×	1.4k 1.1×	1.3k 1.0×	314 0.5×	648 1.4×	89	3.1k
Laura van’t Veer United States	22	1.8k 1.2×	1.3k 1.0×	1.7k 1.3×	1.5k 2.5×	690 1.5×	54	4.0k
Federico A. Monzon United States	34	1.5k 1.0×	2.2k 1.7×	1.6k 1.2×	388 0.7×	940 2.0×	114	4.4k
Annuska M. Glas Netherlands	36	2.7k 1.8×	1.9k 1.5×	2.7k 2.1×	661 1.1×	1.3k 2.7×	97	5.3k
Maria Isabel Achatz Brazil	26	1.1k 0.7×	1.6k 1.2×	1.6k 1.2×	887 1.5×	559 1.2×	115	3.2k
Paul Roepman Netherlands	26	1.1k 0.7×	1.3k 1.0×	1.4k 1.1×	210 0.4×	673 1.4×	82	2.9k
Maria Schwaederlé United States	28	1.7k 1.1×	1.0k 0.8×	1.5k 1.2×	235 0.4×	611 1.3×	43	3.2k
Melanie Trivett Australia	13	695 0.5×	1.2k 0.9×	1.0k 0.8×	145 0.2×	290 0.6×	16	2.4k
Nicolas Stransky United States	17	837 0.6×	2.1k 1.6×	832 0.6×	476 0.8×	315 0.7×	27	3.2k
Étienne Rouleau France	28	1.1k 0.8×	1.2k 0.9×	1.1k 0.8×	561 0.9×	652 1.4×	110	2.7k

Countries citing papers authored by Arno Floore

Since Specialization

Citations

This map shows the geographic impact of Arno Floore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arno Floore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arno Floore more than expected).

Fields of papers citing papers by Arno Floore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arno Floore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arno Floore. The network helps show where Arno Floore may publish in the future.

Co-authorship network of co-authors of Arno Floore

This figure shows the co-authorship network connecting the top 25 collaborators of Arno Floore. A scholar is included among the top collaborators of Arno Floore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arno Floore. Arno Floore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heideman, Daniëlle A.M., Lise M.A. De Strooper, Renske D.M. Steenbergen, et al.. (2021). Classification of high‐grade cervical intraepithelial neoplasia by p16^ink4a, Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management. International Journal of Cancer. 149(3). 707–716. 27 indexed citations

Keer, Severien Van, Pierre Van Damme, Koen Beyers, et al.. (2021). Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine. Molecules. 26(7). 1989–1989. 17 indexed citations

Jacob, Laurent, Anke Witteveen, Leonie Delahaye, et al.. (2020). Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial. Communications Biology. 3(1). 397–397. 5 indexed citations

Witteveen, Anke, Leonie Delahaye, Diederik Wehkamp, et al.. (2016). Equivalence of MammaPrint array types in clinical trials and diagnostics. Breast Cancer Research and Treatment. 156(2). 279–287. 36 indexed citations

Groenendijk, Floris H., Wilbert Zwart, Arno Floore, Stephanie Akbari, & René Bernards. (2013). Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics. Breast Cancer Research and Treatment. 140(3). 475–484. 20 indexed citations

Gunvén, Peter, et al.. (2010). Gene expression profiling guiding diagnosis and therapy of rare mammary-like anogenital gland carcinomas. Medical Oncology. 29(1). 127–132. 4 indexed citations

Morawietz, Lars, Arno Floore, Lisette Stork‐Sloots, et al.. (2009). Comparison of histopathological and gene expression-based typing of cancer of unknown primary. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 456(1). 23–29. 10 indexed citations

Roepman, Paul, et al.. (2009). A gene expression profile for detection of sufficient tumour cells in breast tumour tissue: microarray diagnosis eligibility. BMC Medical Genomics. 2(1). 52–52. 9 indexed citations

Mook, Stella, Marjanka K. Schmidt, Britta Weigelt, et al.. (2009). The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age. Annals of Oncology. 21(4). 717–722. 113 indexed citations

10.

Laar, Ryan K. van, Xiaojun Ma, Daphne de Jong, et al.. (2009). Implementation of a novel microarray‐based diagnostic test for cancer of unknown primary. International Journal of Cancer. 125(6). 1390–1397. 41 indexed citations

11.

Roepman, Paul, Jacek Jassem, Egbert F. Smit, et al.. (2008). An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer. Clinical Cancer Research. 15(1). 284–290. 114 indexed citations

12.

Bueno-de-Mesquita, Jolien M., Sabine C. Linn, Richard Keijzer, et al.. (2008). Validation of 70-gene prognosis signature in node-negative breast cancer. Breast Cancer Research and Treatment. 117(3). 483–495. 131 indexed citations

13.

Bridgewater, John, Ryan K. van Laar, Arno Floore, & Laura van’t Veer. (2008). Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. British Journal of Cancer. 98(8). 1425–1430. 78 indexed citations

14.

Ach, Robert A., Arno Floore, Bo Curry, et al.. (2007). Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools. BMC Genomics. 8(1). 148–148. 41 indexed citations

15.

Buyse, Marc, Sherene Loi, Laura van’t Veer, et al.. (2006). Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 98(17). 1183–1192. 842 indexed citations breakdown →

16.

Glas, Annuska M., Arno Floore, Leonie Delahaye, et al.. (2006). Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics. 7(1). 278–278. 343 indexed citations

17.

Szabo, Csilla I., Mieke Schutte, Annegien Broeks, et al.. (2004). Are ATM Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles?. Cancer Research. 64(3). 840–843. 43 indexed citations

18.

Michalides, Rob, Alexander Griekspoor, Astrid Balkenende, et al.. (2004). Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer. Cancer Cell. 5(6). 597–605. 208 indexed citations

19.

Broeks, Annegien, Jos Urbanus, Peter de Knijff, et al.. (2003). IVS10–6T>G, an ancient ATM germline mutation linked with breast cancer. Human Mutation. 21(5). 521–528. 22 indexed citations

20.

Broeks, Annegien, Jos Urbanus, Arno Floore, et al.. (2000). ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility. The American Journal of Human Genetics. 66(2). 494–500. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact